Doxorubicin–Cisplatin Conjugated Anticancer Drug forLiposomal Co-Delivery
碩士 === 國立臺灣大學 === 化學研究所 === 107 === Cancer is a leading cause of death worldwide and is expected to become even more problematic due to the expanding population and aging. Although several kinds of treatments have been introduced to kill cancer cells, there is still a lot of room for improvement o...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/7vteuq |